Belgium· BE-AMP-SAM311683-00

Avamys 27.5 µg/dose

A fluticasone furoate product containing fluticasone furoate, registered in Belgium by GlaxoSmithKline Trading Services. The same ATC class is registered in 11 of our 19 countries.

ATC R01AD12

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about fluticasone furoateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Fluticasone furoate is registered in 11 of 19 countries.

Countries holding a registration under ATC R01AD12 (fluticasone furoate), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
7 of them publish a price we can compare per daily dose

Search fluticasone furoate products by name

Fluticasone furoate · ATC R01AD12

11 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Fluticasone Furoate
Manufacturer: GlaxoSmithKline Trading Services
Country: Belgium (BE)
ATC code: R01AD12
ATC class: Fluticasone furoate
Defined daily dose: 0.11 mg, N
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 2

1 priced

be_apb
2470706
EUR 13.77
be_apb
0789990

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

55 interactions on record for fluticasone furoate.

Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check fluticasone furoate against other medicines How interaction checks work

Fluticasone furoate · interactions on record

55 records

29 severe
25 moderate
1 minor

Most severe, free to view

LonafarnibA16AX20severe
ConivaptanC03XA02severe
KetoconazoleH02CA03severe
TroleandomycinJ01FA08severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fluticasone furoate in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fluticasone furoate products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Flixonase Aquosum, Flixotide Diskus Forte
Bulgaria · Аркуист, Фликсоназе
Cyprus · Cutivate, Flixonase Aqueous
Czechia · Flixotide Diskus, Flixotide Inhaler N
Germany · Flutica, Fluticason Cipla
Denmark · Flixotide, Flurhin
Estonia · Cutivate Cream, Flixonase
Spain · Avancort, Flixonase
Finland · Flixonase, Flixotide Diskus
France · Fixorinox, Flixonase
United Kingdom (Northern Ireland) · Aeronate, Boots Allergy Relief
Greece · Alerxem, Bocacort-S
Croatia · Flixonase, Flixotide Inhaler
Hungary · Cutivate, Flixonase
Ireland · Arquist, Flixonase Allergy Relief
Iceland · Avamys, Flixotide
Italy · Aktanos, Deflut
Liechtenstein · Avamys
Lithuania · Cutivate, Flixotide
Luxembourg · Flixonase Aqua, Flixotide
Latvia · Flixonase, Flixotide
Malta · Cutivate, Flihaler
Netherlands · Cortifil, Cutivate
Norway · Avamys, Flurhin
Poland · Cutivate, Fanipos
Portugal · Brisovent Diskus, Brisovent Inalador
Romania · Arquist, Cutivate
Sweden · Arquist, Fluticasone Cipla
Slovenia · Flixonase, Flixotide
Slovakia · Flixonase Aqueous, Flixotide Diskus

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/54d90699-3968-4d61-83fe-9930393948f1
GET /v1/drugs/54d90699-3968-4d61-83fe-9930393948f1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Nasal spray, suspension",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Avamys 27.5 µg/dose",
  "name_fr": "Avamys 27.5 µg/dose",
  "name_nl": "Avamys 27.5 µg/dose",
  "amp_code": "SAM311683-00",
  "strengths": [
    "27.5000",
    "27.5000",
    "8.2500",
    "8.2500"
  ],
  "pack_count": 3,
  "substances": [
    "Fluticasone Furoate",
    "Benzalkonium Chloride",
    "Disodium Edetate",
    "Glucose Anhydrous",
    "Polysorbate 80"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Fluticasone Furoate",
  "authorisation_numbers": [
    "EU/1/07/434/001",
    "EU/1/07/434/002",
    "EU/1/07/434/003"
  ]
}

API reference MCP server Plans

See everything about fluticasone furoate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console